Medical devices — US PTAB Patent Cases
522 decisions indexed
Page 18 of 18 · 522 total
VIVITRO LABS INC. v.BIOMEDICAL DEVICE CONSULTANTS & LABORATORIES OF COLORADO, LLC
Vivitro Labs and the patent owner settled their IPR dispute over a biomedical device patent, leading the Board to terminate the proceeding and keep the settlement confidential.
VIVITRO LABS INC. v.BIOMEDICAL DEVICE CONSULTANTS & LABORATORIES OF COLORADO, LLC
VIVITRO Labs and Biomedical Device Consultants & Laboratories of Colorado have settled their dispute over U.S. Patent 9,237,935, filing a joint motion to terminate the ongoing IPR and keep settlement documents confidential.
Ilooda Co., Ltd. et al. v.Serendia, LLC
The Board granted a joint motion to terminate the IPR as to Jeisys Medical Inc. following a settlement with Serendia, while allowing EndyMed petitioners to continue the review.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia seeks Director Review to vacate the Board’s institution of an IPR against its dermatological device patent after the ITC upheld the patent’s validity. The request cites the recent recission of the Fintiv memo and extraordinary circumstances that favor a discretionary denial under § 314(a).
Ilooda Co., Ltd. et al. v.Serendia, LLC
Jeisys Medical Inc. and Serendia, LLC have settled their dispute over U.S. Patent 10,869,812. The parties filed a joint motion to terminate the inter partes review, citing the settlement and lack of substantive briefing.
Ilooda Co., Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia, LLC entered a settlement that resolved all disputes over three patents, leading the PTAB to terminate the associated IPRs. The settlement agreement was deemed confidential business information.
Ilooda Co., Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia, LLC filed a joint request to keep their settlement agreement confidential under 35 U.S.C. § 317(b) and related regulations. The request seeks to separate the agreement from the patent file and limit its disclosure.
Ilooda Co., Ltd. et al. v.Serendia, LLC
EndyMed Medical and Serendia have settled their dispute over U.S. Patent 10,869,812. The parties filed a joint motion to terminate the inter partes review, citing the settlement and lack of oral hearing. The Board is asked to dismiss the proceeding in its entirety.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Serendia, LLC and Jeisys Medical Inc. jointly filed a request with the PTAB to keep their settlement agreement confidential and separate from the patent file, invoking 35 U.S.C. §317(b).
Ilooda Co., Ltd. et al. v.Serendia, LLC
Ilooda and Serendia have filed a joint motion to terminate Ilooda’s participation in an IPR over U.S. Patent 10,869,812, citing a settlement of their dispute. The Board has not yet ruled on institution, and the parties also request the settlement be kept confidential.
Ilooda Co., Ltd. et al. v.Serendia, LLC
Ilooda Co. challenges Serendia's patent (10869812) in an IPR based on anticipation and obviousness, focusing on microneedling technology. The petitioner argues that prior art references like Mehta render multiple claims unpatentable through various combinations of elements.
Ilooda Co., Ltd. et al. v.Serendia, LLC
The PTAB institution decision found a reasonable likelihood of unpatentability for several claims in the dermatological treatment patent, primarily based on anticipation by reference Mehta. The Board rejected arguments for discretionary denial and proceeded with the IPR.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.